OFIX Relative Valuation
OFIX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OFIX is overvalued; if below, it's undervalued.
Historical Valuation
Orthofix Medical Inc (OFIX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -11.60. The fair price of Orthofix Medical Inc (OFIX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：15.43
Fair
-9.30
PE
1Y
3Y
5Y
Trailing
Forward
8.12
EV/EBITDA
Orthofix Medical Inc. (OFIX) has a current EV/EBITDA of 8.12. The 5-year average EV/EBITDA is 9.95. The thresholds are as follows: Strongly Undervalued below 4.12, Undervalued between 4.12 and 7.04, Fairly Valued between 12.86 and 7.04, Overvalued between 12.86 and 15.78, and Strongly Overvalued above 15.78. The current Forward EV/EBITDA of 8.12 falls within the Historic Trend Line -Fairly Valued range.
-14.33
EV/EBIT
Orthofix Medical Inc. (OFIX) has a current EV/EBIT of -14.33. The 5-year average EV/EBIT is -556.09. The thresholds are as follows: Strongly Undervalued below -5304.36, Undervalued between -5304.36 and -2930.23, Fairly Valued between 1818.05 and -2930.23, Overvalued between 1818.05 and 4192.19, and Strongly Overvalued above 4192.19. The current Forward EV/EBIT of -14.33 falls within the Historic Trend Line -Fairly Valued range.
0.73
PS
Orthofix Medical Inc. (OFIX) has a current PS of 0.73. The 5-year average PS is 0.98. The thresholds are as follows: Strongly Undervalued below 0.14, Undervalued between 0.14 and 0.56, Fairly Valued between 1.40 and 0.56, Overvalued between 1.40 and 1.82, and Strongly Overvalued above 1.82. The current Forward PS of 0.73 falls within the Historic Trend Line -Fairly Valued range.
6.86
P/OCF
Orthofix Medical Inc. (OFIX) has a current P/OCF of 6.86. The 5-year average P/OCF is 18.68. The thresholds are as follows: Strongly Undervalued below -35.77, Undervalued between -35.77 and -8.54, Fairly Valued between 45.90 and -8.54, Overvalued between 45.90 and 73.13, and Strongly Overvalued above 73.13. The current Forward P/OCF of 6.86 falls within the Historic Trend Line -Fairly Valued range.
97.37
P/FCF
Orthofix Medical Inc. (OFIX) has a current P/FCF of 97.37. The 5-year average P/FCF is -482.39. The thresholds are as follows: Strongly Undervalued below -4587.40, Undervalued between -4587.40 and -2534.89, Fairly Valued between 1570.12 and -2534.89, Overvalued between 1570.12 and 3622.63, and Strongly Overvalued above 3622.63. The current Forward P/FCF of 97.37 falls within the Historic Trend Line -Fairly Valued range.
Orthofix Medical Inc (OFIX) has a current Price-to-Book (P/B) ratio of 1.40. Compared to its 3-year average P/B ratio of 1.07 , the current P/B ratio is approximately 31.10% higher. Relative to its 5-year average P/B ratio of 1.39, the current P/B ratio is about 1.15% higher. Orthofix Medical Inc (OFIX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -9.28%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -5.26% , the current FCF yield is about -100.00% lower.
1.40
P/B
Median3y
1.07
Median5y
1.39
-0.47
FCF Yield
Median3y
-9.28
Median5y
-5.26
Competitors Valuation Multiple
The average P/S ratio for OFIX's competitors is 1.12, providing a benchmark for relative valuation. Orthofix Medical Inc Corp (OFIX) exhibits a P/S ratio of 0.73, which is -34.71% above the industry average. Given its robust revenue growth of 4.59%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of OFIX decreased by 11.28% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 196.61M to 205.63M.
The secondary factor is the P/E Change, contributed 4.52%to the performance.
Overall, the performance of OFIX in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Orthofix Medical Inc (OFIX) currently overvalued or undervalued?
What is Orthofix Medical Inc (OFIX) fair value?
How does OFIX's valuation metrics compare to the industry average?
What is the current P/B ratio for Orthofix Medical Inc (OFIX) as of Dec 13 2025?
What is the current FCF Yield for Orthofix Medical Inc (OFIX) as of Dec 13 2025?
What is the current Forward P/E ratio for Orthofix Medical Inc (OFIX) as of Dec 13 2025?